Structured Review

BioEos Ltd m vaccae
The results of Phase III one-month trial of daily oral <t> M. vaccae </t> as an immune adjunct to TB therapy.
M Vaccae, supplied by BioEos Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m vaccae/product/BioEos Ltd
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
m vaccae - by Bioz Stars, 2024-06
86/100 stars

Images

1) Product Images from "Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month"

Article Title: Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month

Journal: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

doi: 10.1016/j.jctube.2019.100141

The results of Phase III one-month trial of daily oral  M. vaccae  as an immune adjunct to TB therapy.
Figure Legend Snippet: The results of Phase III one-month trial of daily oral M. vaccae as an immune adjunct to TB therapy.

Techniques Used:

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    BioEos Ltd m vaccae
    The results of Phase III one-month trial of daily oral <t> M. vaccae </t> as an immune adjunct to TB therapy.
    M Vaccae, supplied by BioEos Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/m vaccae/product/BioEos Ltd
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    m vaccae - by Bioz Stars, 2024-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    The results of Phase III one-month trial of daily oral  M. vaccae  as an immune adjunct to TB therapy.

    Journal: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

    Article Title: Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month

    doi: 10.1016/j.jctube.2019.100141

    Figure Lengend Snippet: The results of Phase III one-month trial of daily oral M. vaccae as an immune adjunct to TB therapy.

    Article Snippet: In this study, we have used strain of M. vaccae provided by BioEos, which is the same NCTC 11659 strain we have received from Immodulon for our Phase II trial .

    Techniques: